Overview
NAARI PTE LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering MIFEPRISTONE; NORETHINDRONE; NORETHINDRONE ACETATE.
API / Drug Master Files
NAARI PTE LTD holds 3 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- MIFEPRISTONEActive2022-05-12
- NORETHINDRONE ACETATEActive2021-07-04
- NORETHINDRONEActive2021-03-30
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to NAARI PTE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.